LloydsPharmacy’s superintendent pharmacist Professor Steve Howard will retire at the end of this year, after 35 years with the company.
Related Article: CPhO: ‘Ambition’ to explore weight-loss meds through non-GP routes
Professor Howard’s successor will be announced ‘in the next few weeks’, LloydsPharmacy said, but he will stay on as a part-time non-executive adviser to Lloyds’ parent company, McKesson UK, to oversee collective clinical standards and governance procedures.
Related Article: ICB management cuts will exclude pharmacy commissioning
Professor Howard joined LloydsPharmacy as a pharmacy manager, after starting his career as a hospital pharmacist. He is also a fellow of the Royal Pharmaceutical Society and serves as a visiting professor at the University of Huddersfield and the University of East Anglia.
Related Article: New training for pharmacists to support veterans
Toby Anderson, McKesson UK’s CEO, said: ‘Steve has made a great contribution throughout his career with our business and I would like to say a huge thank you to him for his dedication, service, leadership and professional guidance over the years and in particular during the recent considerable period of change.’
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.